Neurogene shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and $46 price target.

Neurogene, Inc. - Common Stock +1.97% Post

Neurogene, Inc. - Common Stock

NGNE

32.11

32.11

+1.97%

0.00% Post

Neurogene shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and $46 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via